quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:15:59·7d
SECFiling
Neurogene Inc. logo

SEC Form DEFA14A filed by Neurogene Inc.

NGNE· Neurogene Inc.
Health Care
Original source

Companies

  • NGNE
    Neurogene Inc.
    Health Care

Recent analyst ratings

  • Jun 17UpdateCraig Hallum$50.00
  • May 16UpdateRobert W. Baird$24.00
  • Jun 27UpdateBMO Capital Markets$65.00
  • Jun 11UpdateRobert W. Baird$54.00
  • Apr 29UpdateLeerink Partners$46.00
  • Mar 21UpdateWilliam Blair$61.00

Related

  • INSIDER3d
    SEC Form 3 filed by new insider Shafer Christina
  • SEC4d
    Neurogene Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
  • PR4d
    Neurogene Appoints Christy Shafer as Chief Commercial Officer and Christine Mikail, J.D., to Board of Directors
  • SEC7d
    SEC Form DEF 14A filed by Neurogene Inc.
  • PR15d
    Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  • INSIDER24d
    SEC Form 4 filed by Cvijic Christine Mikail
  • INSIDER24d
    SEC Form 4 filed by Jordan Julie
  • INSIDER24d
    SEC Form 4 filed by Mcminn Rachel
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022